T4	Treatment 66 91	intraperitoneal cisplatin
T5	Subject 95 106	3 patients.
T6	Effect 39 62	anaphylactoid reactions
T7	Population 95 96	3
T8	Drug 82 91	cisplatin
T9	Route 66 81	intraperitoneal
T3	Adverse_event 63 65	to
E1	Adverse_event:T3